Evaluation of WO2012078210 – development process for the preparation of a DP2 receptor antagonist; Ironwood's first development DP2 antagonist

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1257-1261

Informa Healthcare

Access to resources Recommend Favorite

Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation

By Costantino Luca  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1099-1104

Informa Healthcare

Access to resources Recommend Favorite

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite

Heterocyclic compounds and their uses: a patent evaluation of WO2010151735A2

By Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 803-806

Informa Healthcare

Access to resources Recommend Favorite

Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756)

By Deng Xianming   S. Gray Nathanael  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 709-713

Informa Healthcare

Access to resources Recommend Favorite